Undervalued Stocks Based On Cash Flows

Results

703

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

703 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
11B
zł138.90-4.2%-40.9%zł333.6mzł188.5748.456.8%n/aMedia
BSGR
€5.850%40.6%€492.4m€5.9615.227.7%3.2%Retail
BONEX
SEK 218.20-3.2%-17.6%SEK 14.5bSEK 373.8377.633.8%n/aPharmaceuticals & Biotech
CTEC
UK£2.093.4%-26.9%UK£4.0bUK£2.9831.420.0%2.6%Healthcare
TINS
Rp3,480.0019.6%201.3%Rp25.9tRp4,500.009.619.6%1.8%Materials
IDX
AU$2.073.8%-9.2%AU$771.1mAU$3.1455.032.6%3.5%Healthcare
TE
€36.345.6%4.8%€6.3b€44.2418.413.8%2.8%Energy
MRK
US$114.90-3.9%41.9%US$294.0bUS$129.7431.821.2%3.0%Pharmaceuticals & Biotech
DEZ
€9.937.7%42.0%€1.5b€12.9417.828.5%1.8%Capital Goods
SANOMA
€9.05-0.5%-8.8%€1.5b€12.14100.032.6%4.6%Media
A000660
₩2,382,000.007.5%856.6%₩1687.2t₩2,712,489.0822.541.4%0.1%Semiconductors
141A
JP¥2,744.00-2.5%31.2%JP¥336.5bJP¥4,675.0036.230.5%0.6%Consumer Retailing
EMG
UK£2.964.3%70.2%UK£3.3bUK£3.0725.326.5%4.3%Diversified Financials
1801
HK$76.404.4%-0.9%HK$132.8bHK$117.58140.931.2%n/aPharmaceuticals & Biotech
NCC B
SEK 193.709.0%1.8%SEK 18.8bSEK 220.00205.948.7%4.6%Capital Goods
ASUR B
Mex$516.376.4%-12.2%Mex$148.0bMex$663.7915.813.1%15.5%Transportation
300014
CN¥66.8817.6%57.8%CN¥145.4bCN¥84.4132.432.7%0.7%Capital Goods
PCR
zł66.30-1.5%-4.5%zł1.3bzł82.4121.820.4%7.6%Materials
ABBV
US$221.59-0.7%16.1%US$402.4bUS$253.55108.925.4%3.1%Pharmaceuticals & Biotech
1021
HK$18.48-2.2%n/aHK$10.0bHK$26.5422.487.8%n/aCapital Goods
3526
NT$318.50-7.7%42.2%NT$20.8bNT$415.0018.131.0%5.3%Tech
NREST
SEK 258.50-5.8%55.0%SEK 3.3bSEK 345.0016.412.3%3.3%Consumer Services
CBHB
RM 0.693.8%200.0%RM 1.3bRM 0.7121.59.6%0.4%Capital Goods
LKNC.Y
US$30.56-0.2%-13.4%US$10.0bUS$45.4018.622.2%n/aConsumer Services
Page 1 of 20